Previous Page  8 / 13 Next Page
Information
Show Menu
Previous Page 8 / 13 Next Page
Page Background

Page 23

Notes:

allied

academies

Nov 22-23, 2018 | Paris, France

Joint Event

Nutrition and Health

16

th

International Conference on

26

th

International Conference on

Diabetes and Endocrinology

&

Journal of Insights in Nutrition and Metabolism | Volume 2

Diabetes infection and malaria immunity: A case in diabetic patients in the central region of Ghana

Paulina Ampomah, Quarme Amponsah Boahene

and

Harrison Tawiah Nfodwo

University of Cape Coast, Ghana

I

n Ghana, non-communicable diseases (diabetes and

hypertension) contribute to about 86,000 deaths annually.

NCDs and infectious diseases (malaria and HIV Aids) are

among the top ten killers in Ghana. Both malaria and type 2

diabetes are immune compromised diseases that pose a major

challenge to health and therefore require immediate attention.

We recruited diabetic patients from 9 major hospitals across

the central region of Ghana and obtained about 3milliliters

of venous or finger prick blood after an informed consent

form was signed. We determined fasting blood sugar (FBS)

levels by glucometer and parasitemia by microscopy (n=260).

Plasma was isolated and used to serologically measure specific

antimalarial antibodies to 3 important Plasmodium falciparum

antigens (MSP1; AMA1 and Crude Schizont antigens) and

determined the proportions of white blood cells (WBC) of

importance (neutrophils and lymphocytes) (n=46). Data was

compared healthy individuals (n=56). Anti-diabetic drug in use

was retrieved from patient’s folder to determine drug efficacy.

Preliminary results show a marked increase in antimalarial

specific antibodies to all three P. falciparum antigens and a

moderate rise in WBC counts in diabetic patients compared

to healthy and hypertensive individuals. Only 3.8% of the 260

had malaria parasite in their blood. Patients with high FBS

(>7.0mmol/L) are at 4.2x risk of malaria infection. To conclude,

we show that effective management of diabetes provides

patients with enormous immune protection against themalaria

parasite.

Speaker Biography

Paulina Ampomah graduated from University of Copenhagen, Denmark as a biomedical

scientist with specialty in B cell immunity and lymphocyte exhaustion markers. She is a

lecturer at the University of Cape Coast where she is continuing with her research work.

e:

pampomah@ucc.edu.gh